Brand / Medicines

Our Medicines

    Access the Mundipharma Opioid Analgesic Identification Chart

    Image
    Chart
    Access here

    BUPREDERMAL® PATCH

    transdermal buprenorphine matrix patch

    Product Information Consumer Medicine Information

    MS MONO® CAPSULES

    modified release morphine sulfate

    Product Information Consumer Medicine Information

    NORSPAN® PATCH

    transdermal buprenorphine matrix patch

    Product Information Consumer Medicine Information

    ORDINE® ORAL SOLUTION

    immediate release morphine hydrochloride

      Product Information Consumer Medicine Information

      OXYCONTIN® TABLETS

      modified release oxycodone hydrochloride

      Product Information Consumer Medicine Information

      OXYNORM® INJECTION

      immediate release oxycodone hydrochloride

      Product Information for injection Consumer Medicine Information

      SEVREDOL® TABLETS

      immediate release morphine sulfate

      Product Information Consumer Medicine Information

      TARGIN® TABLETS

      modified release oxycodone and modified release naloxone hydrochloride dihydrate

      Product Information Consumer Medicine Information

      MS CONTIN® TABLETS

      modified release morphine sulfate

      Product Information Consumer Medicine Information

      DILAUDID® TABLETS

      immediate release hydromorphone hydrochloride

      Product Information Consumer Medicine Information

      DILAUDID® & DILAUDID®HP INJECTIONS

      hydromorphone hydrochloride

      Product Information for injection Consumer Medicine Information

      Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is required at initiation, maintenance and tapering of opioid therapy.

       

      Mundipharma is not promoting the use of strong opioids (excluding the 7-day buprenorphine transdermal patch) in chronic non-cancer pain.

       

      ® MS MONO, NORSPAN, OXYCONTIN, OXYNORM, SEVREDOL, MS CONTIN, DILAUDID and TARGIN are registered trade marks of Mundipharma.
      ® ORDINE is a registered trade mark of Pfizer (Perth) Pty Ltd and is used under licence.

      Reporting adverse events

      Adverse events should be reported. Reporting forms and information can be found at https://aems.tga.gov.au/

      Adverse events can also be reported to Mundipharma at drugsafety@mundipharma.com.au